Neele Reiss1, Klaus Lieb1, Arnoud Arntz2, Ida A Shaw3, Joan Farrell3. 1. University Medical Center Mainz, Germany. 2. Maastricht University, The Netherlands. 3. Indiana University School of Medicine/Midtown CMHC, Schema Therapy Institute Midwest, Indianapolis, USA.
Abstract
BACKGROUND: Schema Therapy (ST), a psychotherapy model integrating cognitive, experiential and behavioural interventions, was initially developed and evaluated as an outpatient treatment for patients with severe and chronic disorders, among them Borderline Personality Disorder (BPD). Two randomized controlled trials have demonstrated the effectiveness of ST for BPD, delivered in an individual or group format, in the outpatient setting. However, the most severely impaired BPD patients are referred to inpatient treatment due to suicidality and severe self-harm. Specialized inpatient treatment programs are limited, with little evaluative research. AIMS: The pilot studies are designed to be first steps in naturalistic clinical settings to evaluate the effects of an intensive inpatient ST treatment program. METHOD: This report presents the results of three independent uncontrolled pilot studies with a total of 92 BPD patients. The programs combine individual and group modalities and are consistent theoretically with the ST model for BPD patients. RESULTS: RESULTS show that inpatient ST can significantly reduce symptoms of severe BPD and global severity of psychopathology with effect sizes ranging from Cohen's d = 2.84 to Cohen's d = .43. CONCLUSIONS: Differences in the effect sizes across the three pilot studies could be explained by length of treatment, number of group psychotherapists and their training. Although there are limitations to the presented pilot studies such as differences in the samples, treatment settings, variations in the treatment itself and the use of different measures, which may have influenced outcome, they are a starting point for describing and evaluating inpatient treatment for BPD in naturalistic settings.
BACKGROUND: Schema Therapy (ST), a psychotherapy model integrating cognitive, experiential and behavioural interventions, was initially developed and evaluated as an outpatient treatment for patients with severe and chronic disorders, among them Borderline Personality Disorder (BPD). Two randomized controlled trials have demonstrated the effectiveness of ST for BPD, delivered in an individual or group format, in the outpatient setting. However, the most severely impaired BPDpatients are referred to inpatient treatment due to suicidality and severe self-harm. Specialized inpatient treatment programs are limited, with little evaluative research. AIMS: The pilot studies are designed to be first steps in naturalistic clinical settings to evaluate the effects of an intensive inpatient ST treatment program. METHOD: This report presents the results of three independent uncontrolled pilot studies with a total of 92 BPD patients. The programs combine individual and group modalities and are consistent theoretically with the ST model for BPD patients. RESULTS: RESULTS show that inpatient ST can significantly reduce symptoms of severe BPD and global severity of psychopathology with effect sizes ranging from Cohen's d = 2.84 to Cohen's d = .43. CONCLUSIONS: Differences in the effect sizes across the three pilot studies could be explained by length of treatment, number of group psychotherapists and their training. Although there are limitations to the presented pilot studies such as differences in the samples, treatment settings, variations in the treatment itself and the use of different measures, which may have influenced outcome, they are a starting point for describing and evaluating inpatient treatment for BPD in naturalistic settings.
Authors: Ole Jakob Storebø; Jutta M Stoffers-Winterling; Birgit A Völlm; Mickey T Kongerslev; Jessica T Mattivi; Mie S Jørgensen; Erlend Faltinsen; Adnan Todorovac; Christian P Sales; Henriette E Callesen; Klaus Lieb; Erik Simonsen Journal: Cochrane Database Syst Rev Date: 2020-05-04
Authors: Eva Fassbinder; Maren Schuetze; Annika Kranich; Valerija Sipos; Fritz Hohagen; Ida Shaw; Joan Farrell; Arnoud Arntz; Ulrich Schweiger Journal: Front Psychol Date: 2016-11-25
Authors: Caroline Schaitz; Julia Kroener; Anna Maier; Bernhard J Connemann; Zrinka Sosic-Vasic Journal: Front Psychiatry Date: 2020-05-20 Impact factor: 4.157
Authors: Yeow May Tan; Christopher W Lee; Lynn E Averbeck; Odette Brand-de Wilde; Joan Farrell; Eva Fassbinder; Gitta A Jacob; Desiree Martius; Sophie Wastiaux; Gerhard Zarbock; Arnoud Arntz Journal: PLoS One Date: 2018-11-21 Impact factor: 3.240